On that note, these data suggest that cancer cells arising from a number of lymphocyte lineages, like AML cells6, might be sensitive to DPP8/9 inhibitors, but also indicates more potential for toxicity, particularly in humans. The gene discussed is DPP8; the disease is cancer.